|
A Potent, orally-active HDAC inhibitor for the treatment of haematologic malignancies and solid tumors. Translational Cancer Medicine, Sangthongpitag K, Wang H, Stunkel W, Bonday Z, Goh KC, Wang X, Wu XF, Hu CY, Sun E, Entzeroth M, Reddy V, Goh E, Yeo P, Chen CS, Greicius G, Pettersson S, Ethirajulu K, Wood J. AACR Centennial Conference 2007 Nov 4-8 Singapore: Poster Session C14. ( 9/2007 - 9/2008 )
|